Peter Honig is a director of Karyopharm Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Karyopharm Therapeutics Inc.
25 May 23
4
Sesen Bio, Inc.
24 Jun 22
4
Karyopharm Therapeutics Inc.
20 May 22
4
Karyopharm Therapeutics Inc.
7 Dec 21
3
Karyopharm Therapeutics Inc.
7 Dec 21
4
Sesen Bio, Inc.
21 Jul 21
3
Sesen Bio, Inc.
21 Jul 21
4
Orexigen Therapeutics, Inc.
18 Jul 17
4
Orexigen Therapeutics, Inc.
14 Jul 16
4
Orexigen Therapeutics, Inc.
10 Jun 15
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 May 23 | KPTI Karyopharm Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.5 | 34,000 | 85.00 k | 34,000 |